REGENEUS LTD (ASX:RGS)
Industry: Classification Pending
Activity: Regenerative medicine.
25 Bridge Street PYMBLE NSW 2073
Ph: (02) 9499 8010    Fax: (02) 9499 8020
Duncan Thomson
Wed, 13 Nov 2013 1:30pm
Duncan Thomson, Head of Animal Health
Icon_lastIcon_nextIcon_previousIcon_first
Interim Results
Thu, 19 Feb 2015
Annual General Meeting
Tue, 28 Oct 2014
Full Year Results
Mon, 25 Aug 2014
Interim Results
Thu, 27 Feb 2014
Annual General Meeting
Wed, 27 Nov 2013
Response to ASX Price Query Wed, 9 Mar 2016
Half Year Results Announcement Mon, 29 Feb 2016
Appendix 4D and Half Yearly Report Mon, 29 Feb 2016
Appendix 4C - Quarterly Thu, 28 Jan 2016
Positive safety of first cohort in Progenza stem cell trial Tue, 12 Jan 2016
Patent granted for cancer vaccine technology Tue, 15 Dec 2015
Regeneus to present at Austrade Mission on Regenmed in Japan Mon, 7 Dec 2015
Presentation for Austrade Mission on Regenmed in Japan Mon, 7 Dec 2015
Canine cancer vaccine trial on lymphoma at SASH commenced Thu, 26 Nov 2015
High potency stem cells for next generation cell therapies Tue, 24 Nov 2015

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.